Filtered By:
Source: Hematology
Cancer: Non-Hodgkin's Lymphoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
CONCLUSION AND DISCUSSION: Our data support a role for ADAM12 in NHL cell proliferation, adhesion, and drug resistance, and it may pave the way for a novel therapeutic approach for CAM-DR in NHL.
PMID: 28395594 [PubMed - as supplied by publisher]
Source: Hematology - April 12, 2017 Category: Hematology Tags: Hematology Source Type: research
